Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?

1. YachDFeldmanZABradleyDGKhanM

2010

Can the food industry help tackle the growing burden of

undernutrition?

Am J Public Health

100

974

980

2. RamptonSStauberJ

2010

Trust us, we're experts: How industry manipulates science

and gambles with your future.

Penguin

3. PintoSLipowskiESegalRKimberlinCAlginaJ

2007

Physicians' intent to comply with the American Medical

Association's guidelines on gifts from the pharmaceutical

industry.

J Med Ethics

33

313

319

4. SufrinCRossJS

2008

Pharmaceutical industry marketing: Understanding its impact on

women's health.

Obstet Gynecol Surv

63

585

596

5. BrownellKWarnerKE

2009

The perils of ignoring history: Big Tobacco played dirty and

millions died. How similar is Big Food?

Milbank Quarterly

87

259

294

6. WiistW

2010

The bottom line or public health: Tactics corporations use to

influence health and health policy, and what we can do to counter

them.

New York

Oxford University Press

7. Moss M (29 May 2010) The hard sell on salt. New York Times. Available:

http://www.nytimes.com/2010/05/30/health/30salt.html.

Accessed 10 March 2011

8. WedelJ

2001

Collision and Collusion: The strange case of Western aid to

Eastern Europe.

New York

St. Martin's

9. WestadO

2005

The global Cold War: Third world interventions and the making of

our times.

Cambridge

Cambridge University Press

10. EasterlyW

2006

The white man's burden.

Lancet

367

2060

11. MoyoD

2009

Dead aid: Why aid is not working and how there is another way for

Africa.

New York

Penguin

12. BenatarS

1998

Imperialism, research ethics and global health.

J Med Ethics

24

221

222

13. Global Health Watch

2009

Global Health Watch 2. London: Zed Books. Available: http://www.ghwatch.org/ghw2/report-summary. Accessed 10

March 2011

14. KleinN

2008

The shock doctrine: The rise of disaster

capitalism.

London

Penguin

15. ChangH

2009

Bad samaritans: The myth of free trade and the secret history of

capitalism.

Bloomsbury Publishing USA

16. SridharDBatnijiR

2008

Misfinancing global health: A case for transparency in

disbursements and decision making.

Lancet

372

1185

1191

17. StucklerDRobinsonHMcKeeMKingL

2008

World Health Organisation budget and burden of disease: A

comparative analysis.

Lancet

372

1563

1569

18. FaragMNandakumarAKWallackSSGaumerGHodgkinD

2009

Does funding from donors displace government spending for health

in developing countries?

Health Affairs

28

1045

1055

19. GarnerB

2009

Black's Law dictionary.

St Paul, MN

West Publishing

20. Wikipedia

2011

Conflict of interest. Wikipedia. Available: http://en.wikipedia.org/wiki/Conflict_of_interest. Accessed

10 March 2011

21. StuddertDMelloMMBrennanTA

2004

Financial conflicts of interest in physicians' relationships

with the pharmaceutical industry – Self regulation in the shadow of

federal prosecution.

New Eng J Med

351

1891

1900

22. BarnesDBeroLA

1996

Industry-funded research and conflict of interest: an analysis of

research sponsored by the tobacco industry through the Center for Indoor Air

Research.

J Health Polit Policy Law

21

515

542

23. World Health Organization. Roll Back Malaria Partnership: Conflict of

interest policy and procedure. Available: http://www.rbm.who.int/docs/constituencies/RBMcoiPolicy.pdf.

Accessed 10 March 2011

24. McCoyDKembhaviGPatelJLuintelA

2009

The Bill & Melinda Gates Foundation's grant-making

programme for global health.

Lancet

373

1645

1653

25. RavishankarNGubbinsPCooleyRJLeach-KemonKMichaudCMJamisonDTMurrayCJ

2009

Financing of global health: Tracking development assistance for

health from 1990 to 2007.

Lancet

373

2113

2124

26. OomsGStucklerDBasuSMcKeeM

2010

Financing the Millennium Development Goals for health and beyond:

Sustaining the 'Big Push'. Globalization and Health 6: 17.

Available: http://www.globalizationandhealth.com/content/6/1/17.

Accessed 10 March 2011

27. McCoyDChandSSridharD

2009

Global health funding: How much, where it comes from and where it

goes.

Health Policy Plan

24

407

417

28. Abelson R (11 June 2000) Charities' Investing: Left hand, meet

right. New York Times. New York. Available: http://www.nytimes.com/2000/06/11/business/charities-investing-left-hand-meet-right.html.

Accessed 10 March 2011

29. Hilton Foundation

2011

Hilton in the community foundation: About us. Hilton Foundation.

Available: http://www.hilton-foundation.org.uk/about%20us.htm. Accessed

10 March 2011

30. WerbelJCarterSM

2002

The CEO's influence on corporate foundation

giving.

J Bus Ethics

40

47

60

31. DomhoffG

2009

The power elite and their challengers.

Am Behav Sci

52

955

973

32. BondMGlouharovaSHarriganN

2006

The effects of intercorporate networks on corporate social and

political behaviour: ESRC Final Report. Available: http://www.mysmu.edu/faculty/nharrigan/2006,%20ESRC%20Final%20Report.pdf.

Accessed 10 March 2011

33. MillsCWolfeA

2000

The power elite.

Oxford

Oxford University Press

34. DomhoffG

1967

Who rules America?

Englewood Cliffs, NJ

Prentice-Hall

35. DomhoffG

2009

How to do power structure research. University of California Santa

Cruz. Available: http://sociology.ucsc.edu/whorulesamerica/methods/how_to_do_power_structure_research.html.

Accessed 10 March 2011

36. NaderL

1972

Up the anthropologist – Perspectives gained from studying

up.

Rethinking anthropology. Pantheon Books

37. SmithD

2005

Institutional ethnography: A sociology for

people.

Oxford

AltaMira Press

38. MarcusG

1998

Ethnography through thick and thin.

Princeton, NJ

Princeton University Press

39. StoneD

2001

Policy paradox: The art of political

decision-making.

W W Norton & Co Inc

40. NyeJ

2004

Soft power.

Foreign Policy

80

153

171

41. LukesS

1974

Power: A radical view.

London

Macmillan Press

42. FoucaultMGordonC

1980

Power/knowledge: Selected interviews and other writings,

1972–1977: Pantheon

43. BuffettW

2010

My philanthropic pledge. Forbes. Available: http://money.cnn.com/2010/06/15/news/newsmakers/Warren_Buffett_Pledge_Letter.fortune/.

Accessed 10 March 2011

44. Securities and Exchange Commission

2010

Edgar database. Bill & Melinda Gates Foundation Trust filings.

Available: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001166559&owner=exclude&count=40.

Accessed 10 March 2011

45. Bill & Melinda Gates Foundation Trust

2009

Return of Private Foundation. Form 990-PF. Department of the Treasury,

Internal Revenue Service. Available: http://nccsdataweb.urban.org/PubApps/showOrgsByCategory.php?group=pf.

Accessed 10 March 2011

46. HodgsonJ

2009

Gates Foundation sells off pharmaceutical holdings. New York: Wall

Street Journal. Available: http://online.wsj.com/article/SB125029373754433433.html.

Accessed 10 March 2011

47. MarketWatch (22 April 2010) As American as whole-grain chips: PepsiCo

tries to appeal to our better angels. Available: http://www.marketwatch.com/story/pepsico-appeals-to-our-better-angels-2010-04-22.

Accessed 10 March 2011

48. CNBC (1 July 2010) Warren Buffett's $1.6 billion stock

donation to Gates Foundation lifts 5-Year total to $8 billion.

Available: http://www.cnbc.com/id/38046115/Warren_Buffett_s_1_6_Billion_Stock_Donation_to_Gates_Foundation_Lifts_5_Year_Total_to_8_Billion.

Accessed 10 March 2011

49. National Center for Charitable Statistics

2011

NCCS P990 Internal Revenue Service Database: Urban Institute. http://nccsdataweb.urban.org/PubApps/990search.php/.

Accessed 10 March 2011

50. Ford Foundation

2009

Return of Private Foundation. Form 990-PF: Department of the Treasury,

Internal Revenue Service. Available: http://nccsdataweb.urban.org/PubApps/showOrgsByCategory.php?group=pf.

Accessed 10 March 2011

51. Rockefeller Foundation

2009

Return of Private Foundation. Form 990-PF: Department of the

Treasury, Internal Revenue Service.

52. W. K. Kellogg Foundation

2009

Return of Private Foundation. Form 990-PF: Department of the Treasury,

Internal Revenue Service. Available: http://nccsdataweb.urban.org/PubApps/showOrgsByCategory.php?group=pf.

Accessed 10 March 2011

53. Robert Wood Johnson Foundation

2009

Return of private foundation. Form I990-PF: Department of the Treasury,

Internal Revenue Service. Available: http://nccsdataweb.urban.org/PubApps/showOrgsByCategory.php?group=pf.

Accessed 10 March 2011

54. Rockefeller Foundation

2011

Social investment guidelines. New York: Rockefeller Foundation.

Available: http://www.rockefellerfoundation.org/uploads/files/af34dcb4-1000-4dde-9748-df58eafc7ae2.pdf.

Accessed 10 March 2011

55. Bill & Melinda Gates Foundation

2010

Conflict of interest policy. Available: http://www.gatesfoundation.org/about/Documents/Conflict_of_Interest_Policy.pdf.

Accessed 10 March 2011

56. Ford Foundation

2011

Mission: Ford Foundation. Available: http://www.fordfoundation.org/about-us/mission. Accessed 10

March 2011

57. Rockefeller Foundation

2011

Moments in time: 1913-1919. Rockefeller Foundation. Available:

http://www.rockefellerfoundation.org/who-we-are/our-history/1913-1919/.

Accessed 10 March 2011

58. GatesB

2010

2010 Annual letter from Bill Gates. Available: http://www.gatesfoundation.org/annual-letter/2010/Pages/bill-gates-annual-letter.aspx.

Accessed 10 March 2011

59. Bill & Melinda Gates Foundation

2011

Kate James, Chief Communication Officer Foundation Operations. Bill

& Melinda Gates Foundation. Available: http://www.gatesfoundation.org/leadership/Pages/kate-james.aspx.

Accessed 10 March 2011

60. Bill & Melinda Gates Foundation

2011

Tachi Yamada, President Global Health Program: Bill & Melinda Gates

Foundation. Available: http://www.gatesfoundation.org/leadership/Pages/tachi-yamada.aspx.

Accessed 10 March 2011

61. Reuters (31 March 2010) Merck exec to be Gates Foundation CFO. Reuters.

Seattle. Available: http://www.reuters.com/article/idUSN3120892820100331.

Accessed 10 March 2011

62. Bill & Melinda Gates Foundation

2011

United States program advisory panel: Anne Fudge. Bill & Melinda

Gates Foundation. Available: http://www.gatesfoundation.org/united-states/Pages/program-advisory-panel.aspx.

Accessed 10 March 2011

63. Bill & Melinda Gates Foundation

2010

The Coca-Cola Company, TechnoServe and The Gates Foundation partner to

boost incomes of 50K small-scale farmers in East Africa. Available:

http://www.gatesfoundation.org/press-releases/Pages/technoserv-empowers-farmers-in-uganda-and-kenya-100120.aspx.

Accessed 10 March 2011

64. GatesM

2010

What we can learn from Coke. TEDxChange. Available: http://www.gatesfoundation.org/tedxchange/Pages/tedxchange-2010.aspx.

Accessed 10 March 2011

65. Johnson & Johnson Foundation

2009

Novel partnerships evolve drug development. Our Responsibility. 2009

Sustainability Report. Available: http://www.investor.jnj.com/2009sustainabilityreport/society/partnerships2.html.

Accessed 10 March 2011

66. EbrahimSSmithGD

2001

Exporting failure? Coronary heart disease and stroke in

developing countries.

Int J Epidemiol

30

201

205

67. World Health Organization

2009

Mortality and burden of disease estimates for WHO Member States

in 2004.

Geneva

World Health Organization

68. SuhrckeMNugentRStucklerDRoccoL

2006

Chronic disease: An economic perspective.

London

Oxford Health Alliance

69. MontagueDFeachemRFeachemNSKoehlmoosTPKinlawH

2009

Oxfam must shed its ideological bias to be taken

seriously.

BMJ

338

b1202

70. PillerCSandersEDixonR

7 January 2007

Dark cloud over good works of Gates Foundation. Los Angeles Times.

Available: http://www.latimes.com/news/la-na-gatesx07jan07,0,2533850.story.

Accessed 10 March 2011

71. Bibbins-DomingoKChertowGMCoxsonPGMoranALightwoodJM

2010

Projected effect of dietary salt reductions on future

cardiovascular disease.

New Engl J Med

362

590

599

72. Robert Wood Johnson Foundation

2010

More than a decade of helping smokers quit: The Robert Wood Johnson

Foundation's Investment in Tobacco Cessation. Appendix 1: Major

Tobacco-Cessation Grants of the Robert Wood Johnson Foundation. Robert Wood

Johnson Foundation. Available: http://www.rwjf.org/pr/product.jsp?id=63799. Accessed 10

March 2011

73. McNeilD

16 February 2008

Gates Foundation's influence criticized. New York Times.

Available: http://www.nytimes.com/2008/02/16/science/16malaria.html?_r=3&ref=health&oref=slogin&oref=login.

Accessed 10 March 2011

74. OomsGHammondR

2009

Scaling up global social health protection: Prerequisite reforms

to the International Monetary Fund.

Int J Health Serv

39

795

801

75. StucklerDBasuSMcKeeM

2011

International Monetary Fund and aid displacement.

Int J Health Services

41

67

76

76. RutledgePCrookesDMcKinstryBMaxwellSR

2003

Do doctors rely on pharmaceutical industry funding to attend

conferences and do they perceive that this creates a bias in their drug

selection? Results from a questionnaire survey.

Pharmacoepidemiol Drug Saf

12

663

667

77. WazanaA

2000

Physicians and the pharmaceutical industry: Is a gift ever just a

gift?

JAMA

283

373

380

78. LexchinJ

1993

Interactions between physicians and the pharmaceutical industry:

What does the literature say?

CMAJ

149

1401

1407

79. SpurlingGKMansfieldPRMontgomeryBDLexchinJDoustJ

2010

Information from pharmaceutical companies and the quality,

quantity, and cost of physicians' prescribing: A systematic

review.

PLoS Med

7

e1000352

doi:10.1371/journal.pmed.1000352

80. SingerN

4 August 2009

Medical papers by ghostwriters pushed therapy. New York Times.

Available: http://www.nytimes.com/2009/08/05/health/research/05ghost.html.

Accessed 10 March 2011

81. WiistB

2010

The corporate playbook, health, and democracy: the snack food and

beverage industry's tactics in context. Ch 6

StucklerDSiegelK

Sick Societies: Responding to the Global Challenge of Chronic

Disease. Oxford University Press. In press